Recent research throws into question whether GLP-1 drugs increase the risk of certain types of thyroid cancer.

GLP-1RAs were not associated with an increased risk for thyroid cancer relative to DPP-4 inhibitor use among an international cohort.

G lucagon-like peptide-1 receptor agonists, aka GLP-1 agonists, such as semaglutide -- better known as Ozempic -- have ...

Stanford Medicine researchers have identified a promising, naturally occurring molecule that could help people lose ...

GLP-1 receptor agonists were initially approved for glycaemic control in type 2 diabetes and, subsequently, for bodyweight loss in obesity. Following large-scale trials demonstrating that some GLP-1 ...

There’s also been concern that GLP-1 drugs might increase the risk of a rare form of thyroid cancer in patients taking immune-suppressing drugs to prevent transplant rejection, researchers added.

Ozempic and other similar drugs must be injected. Messer describes the needle as “small, the size of two human hairs.” ...

Kidney transplant recipients with type 2 diabetes treated with a new class of anti-obesity drugs were less likely to experience organ failure and survived longer, a new study shows.

Kidney transplant recipients with type 2 diabetes treated with a new class of anti-obesity drugs were less likely to ...

A new study suggests that medications commonly used for diabetes, including the popular drug Ozempic, may help reduce the ...

Regular follow-ups can also help doctors monitor signs of hypoglycemia, renal disease, pancreatitis and thyroid cancer. GLP-1 agonists are medications that primarily treat type 2 diabetes and obesity.

GLP-1 drugs like Ozempic can help kidney transplant patients avoid organ failure and live longer, a new study sugges ...